TL;DR
This paper extends the "benefit function" concept from binary treatment/effect scenarios to nonbinary ones, enabling more nuanced decision-making in fields like marketing and healthcare. The authors introduce algorithms to test the identifiability of these nonbinary benefit functions and compute their bounds using experimental and observational data.
What Problem Does This Paper Address?
The "unit selection problem" is about identifying individuals most likely to exhibit a desired behavior or respond to an intervention. For example, a company might want to target promotions to customers who are on the fence about leaving but would reconsider if offered a deal. Traditionally, this has been framed with binary treatments (e.g., offer a deal vs. no deal) and binary outcomes (e.g., churn vs. stay). However, many real-world scenarios involve multiple treatment options and multiple possible outcomes. For instance, a clinical trial might test a vaccine (treatment: vaccinated vs. unvaccinated) with outcomes ranging from uninfected to asymptomatic to severe infection. The challenge is to quantify the "benefit" of an intervention when these choices and outcomes are not simple yes/no decisions. This paper addresses this by generalizing the unit selection framework to handle nonbinary treatments and effects, providing tools to analyze and bound the effectiveness of interventions in these more complex situations.
Methods
The core contribution is the generalization of the "benefit function" to nonbinary treatments and effects. This function quantifies the expected gain from selecting an individual based on their potential responses under different hypothetical scenarios (counterfactuals). The authors build upon previous work (Li and Pearl, 2019, 2022b) which established bounds for probabilities of causation.
Two key algorithms are proposed:
- Algorithm 1: Check Identifiability of the Benefit Function: This algorithm determines if the exact value of a nonbinary benefit function can be uniquely identified using only experimental data. It leverages the structure of the benefit function and experimental data to see if counterfactual terms can be replaced by observed probabilities.
- Algorithm 2: Compute Bounds of the Benefit Function: If the benefit function is not identifiable with experimental data alone, this algorithm computes its bounds using a combination of experimental and observational data. It relies on pre-computed bounds for probabilities of causation (from Li and Pearl, 2022b) and recursively combines them to derive bounds for the overall benefit function.
The algorithms are designed to handle scenarios where the treatment variable $X$ has $m$ values and the outcome variable $Y$ has $n$ values, leading to $m \times n$ possible response types.
Datasets
The paper uses data from a clinical study on vaccine effectiveness as a motivating example and for illustration.
- Experimental Data (Table 1): 600 people were assigned to receive the vaccine, and 600 were assigned to not receive it. Outcomes (uninfected, asymptomatic, severe condition) were recorded.
- Observational Data (Table 2): 1200 people were free to choose whether to take the vaccine. Their choices and outcomes were recorded.
These datasets are used to illustrate the application of the proposed algorithms and theorems.
Key Insights and Ideas
- Generalizing Benefit Functions: The ability to define and bound benefit functions for nonbinary treatments and effects is crucial for making informed decisions in complex, real-world scenarios beyond simple binary choices.
- Identifiability is Key: Not all benefit functions can be precisely determined even with experimental data. Algorithm 1 provides a way to check if a precise value can be found, which is more desirable than just bounds.
- Bounds as a Practical Alternative: When exact identification isn't possible, Algorithm 2 provides valuable bounds on the benefit function. This allows for risk assessment and decision-making under uncertainty.
- Causality is Fundamental: The entire framework relies on causal inference principles, specifically counterfactual reasoning, to understand what would have happened under different conditions.
- Benefit Vector Dictates Identifiability: The specific coefficients (the "benefit vector") in the benefit function play a critical role in determining whether the function is identifiable. This suggests that carefully designing the objective can lead to more precise insights.
Key Results
The paper demonstrates the application of its theorems and algorithms through two tasks related to vaccine effectiveness:
- Task 1 (Binary-like benefit vector): Using a benefit vector that assigns 1 to benefited individuals and -1 to harmed individuals, the benefit function was found to be not identifiable by experimental data alone. Algorithm 2 was used to compute bounds, yielding a range of [-0.228, -0.107]. This suggests the vaccine's effectiveness is at most -0.107 per individual.
- Task 2 (Weighted benefit vector): When the benefit vector was adjusted to give twice the importance to specific beneficial outcomes (assigning 2 and -2), Algorithm 1 determined the benefit function was identifiable by experimental data. The exact value was found to be -0.167.
Simulated results with various benefit vectors showed that the bounds computed by Theorem 2 are good estimations of the "real benefit" (derived from known response type fractions), with lower and upper bounds closely surrounding the real benefit. The average gap between bounds was also shown to be relatively small compared to the largest possible gap.
Limitations and Future Work
- Computational Complexity: The authors acknowledge that Algorithms 1 and 2 have exponential time complexity. However, they argue this is manageable for small numbers of treatment and outcome values ($m$ and $n$), which are often constants in practice.
- Need for Bounds: The paper highlights that even with bounds for individual probabilities of causation, deriving non-trivial bounds for their linear combination (the benefit function) requires specific algorithms like Algorithm 2.
- Future Work:
- Assessing the statistical properties of the bounds (tightness, decision-making utility).
- Investigating the relative impact of experimental vs. observational data on bound quality.
- Exploring how the number of treatment and outcome values affects bound quality.
- Extending the work by incorporating covariate information to further refine the bounds, similar to previous work on binary benefit functions.
Summary updated